To save taxpayer money and rebuild the economy, Congress should repeal Biden's poorly named Inflation Reduction Act ...

Consumer sentiment fell in January for the first time in six months, according to U-M survey. What's next as Trump creates ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

A short statement from CMS said the agency will consider ways to make Medicare price negotiations, begun under Biden, more ...

Senator Rick Scott (R-FL) announced the reintroduction of his Protect Our Seniors Act, a legislative effort aimed at preserving and protecting Social Security ...

Biden-era policies rescinded by Donald Trump could signal a significant shake-up in Medicare and Medicaid drug price reforms.

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 ...

The price negotiation process was established under former President Joe Biden's signature Inflation Reduction Act in 2022.

The second round of Medicare Part D price negotiations will feature two drugs familiar to rheumatologists — Ofev and Otezla — ...

The Centers for Medicare and Medicaid Services (CMS) says about 8,247,000 people with Medicare Part D coverage use the ten drugs selected for price negotiation.

President Donald Trump rescinded an executive order issued by former President Joe Biden aimed at finding new models for ...

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...